Tag #Vaccine Sales

How did the Dutch subsidiary's role in channeling profits from various countries contribute to Pfizer's overall financial picture?

The significant drop in Pfizer's revenue from $74.4 billion in 2022 to $46.9 billion in 2023 is primarily attributed to the decreased demand for Comirnaty and Paxlovid. While this decline impacts Pfizer's overall profits, the company's Dutch subsidiary still oversees the majority of Pfizer's international operations outside of the U.S., channeling profits through the Netherlands.